B. De Lafontan

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases

B. Cutuli, C. Cohen-Solal Le-Nir, D. Serin et al. · Critical Reviews in Oncology/Hematology · 2009 · 181 citations

Prognostic Factors, Surgical Oncology, Breast Oncology +8

Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network

Guilhem Bousquet, C Confavreux, Nicolas Magné et al. · Radiotherapy and Oncology · 2007 · 135 citations

Prognostic Factors, Surgical Oncology, Rare Cancer Network +10

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience

B. Cutuli, C. Cohen-Solal-Le Nir, B. De Lafontan et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 127 citations

Surgical Oncology, Breast Oncology, Medicine +9

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study

Yazid Belkacémi, Joseph Gligorov, Mahmut Özsahin et al. · Annals of Oncology · 2008 · 117 citations · Full text

Breast Oncology, Medicine, Concurrent Trastuzumab +6

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study

H. Mignotte, Christine Lasset, Valérie Bonadona et al. · International Journal of Cancer · 1998 · 101 citations · Full text